Guorong Li

Summary

Country: France

Publications

  1. doi request reprint Detection of urinary cell-free miR-210 as a potential tool of liquid biopsy for clear cell renal cell carcinoma
    Guorong Li
    Department of Urology, North Hospital, CHU of Saint Etienne, University of Jean Monnet, Saint Etienne, France Inserm U1059, Saint Etienne, France Electronic address
    Urol Oncol . 2017
  2. doi request reprint A novel marker ADAM17 for clear cell renal cell carcinomas: implication for patients' prognosis
    Guorong Li
    Department of Urology, North Hospital, CHU de Saint Etienne, University of Jean Monnet, Saint Etienne, France LINA, EA 4624, Faculty of Medicine, University of Jean Monnet, Saint Etienne, France Electronic address
    Urol Oncol 32:1272-6. 2014
  3. doi request reprint Prognostic value of CXCR4 expression in patients with clear cell renal cell carcinoma
    Guorong Li
    Department of Urology, North Hospital, CHU Saint Etienne, University of Jean Monnet, Saint Etienne, France
    Histol Histopathol 28:1217-22. 2013
  4. doi request reprint MN/CA9 as a novel molecular marker for the detection of cancer
    Guorong Li
    Department of Urology, North Hospital, CHU of Saint Etienne, 42055 Saint Etienne Cedex 2, France 33 0 4 77 82 88 14 33 0 4 77 12 05 52
    Expert Opin Med Diagn 1:91-7. 2007
  5. doi request reprint [Clinicopathological study and immunohistochemical expression of CA9 in cystic multilocular renal cell carcinomas]
    G Li
    Service d Urologie Andrologie, Université Jean Monnet, Hopital Nord, CHU de Saint Etienne, 108, Avenue Albert Raimond, 42055 Saint Etienne Cedex 2, France
    Prog Urol 22:572-6. 2012
  6. doi request reprint CA9 as a molecular marker for differential diagnosis of cystic renal tumors
    Guorong Li
    Department of Urology, North Hospital, CHU of Saint Etienne, Faculty of Medicine J Lisfranc, Jean Monnet University, Saint Etienne, France
    Urol Oncol 30:463-8. 2012
  7. ncbi request reprint MN/CA9: a potential gene marker for detection of malignant cells in effusions
    G Li
    Laboratory of Clinical Immunology, North Hospital, CHU of Saint Etienne, France
    Biomarkers 12:214-20. 2007
  8. doi request reprint [Results of fine-needle aspiration cytology (FNAC) in the diagnosis of indeterminate solid renal tumours]
    G Li
    Service d Urologie Andrologie, CHU de Saint Etienne, Université Jean Monnet, Saint Etienne, France
    Prog Urol 20:30-4. 2010
  9. doi request reprint CA9 level in renal cyst fluid: a possible molecular diagnosis of malignant tumours
    Guorong Li
    Department of Urology, North Hospital, CHU of Saint Etienne, Faculty of Medicine, Jean Monnet University, Saint Etienne, France
    Histopathology 54:880-4. 2009
  10. ncbi request reprint S100A1: a powerful marker to differentiate chromophobe renal cell carcinoma from renal oncocytoma
    G Li
    Department of Urology, North Hospital, CHU of Saint Etienne, France
    Histopathology 50:642-7. 2007

Collaborators

Detail Information

Publications33

  1. doi request reprint Detection of urinary cell-free miR-210 as a potential tool of liquid biopsy for clear cell renal cell carcinoma
    Guorong Li
    Department of Urology, North Hospital, CHU of Saint Etienne, University of Jean Monnet, Saint Etienne, France Inserm U1059, Saint Etienne, France Electronic address
    Urol Oncol . 2017
    ..MiR-210 is proven to be overexpressed in patients with a clear cell renal cell carcinoma (ccRCC). The purpose of this pilot study was to examine the urinary cell-free miR-210 as a potential tool of liquid biopsy for ccRCC...
  2. doi request reprint A novel marker ADAM17 for clear cell renal cell carcinomas: implication for patients' prognosis
    Guorong Li
    Department of Urology, North Hospital, CHU de Saint Etienne, University of Jean Monnet, Saint Etienne, France LINA, EA 4624, Faculty of Medicine, University of Jean Monnet, Saint Etienne, France Electronic address
    Urol Oncol 32:1272-6. 2014
    ..Its expression and prognostic value have not been studied in clear cell renal cell carcinoma (cRCC). The objective of this study was to explore the prognostic value of ADAM17 in patients with cRCC...
  3. doi request reprint Prognostic value of CXCR4 expression in patients with clear cell renal cell carcinoma
    Guorong Li
    Department of Urology, North Hospital, CHU Saint Etienne, University of Jean Monnet, Saint Etienne, France
    Histol Histopathol 28:1217-22. 2013
    ..The information on its prognostic value has been very limited in clear cell renal cell carcinoma (ccRCC). Our objective was to explore the prognostic value of CXCR4 in ccRCC...
  4. doi request reprint MN/CA9 as a novel molecular marker for the detection of cancer
    Guorong Li
    Department of Urology, North Hospital, CHU of Saint Etienne, 42055 Saint Etienne Cedex 2, France 33 0 4 77 82 88 14 33 0 4 77 12 05 52
    Expert Opin Med Diagn 1:91-7. 2007
    ..The usefulness of MN/CA9 is also demonstrated for the detection of distant metastasis after surgery. As molecular techniques become routinely available, MN/CA9 is a powerful molecular marker in cancer diagnosis and prognosis...
  5. doi request reprint [Clinicopathological study and immunohistochemical expression of CA9 in cystic multilocular renal cell carcinomas]
    G Li
    Service d Urologie Andrologie, Université Jean Monnet, Hopital Nord, CHU de Saint Etienne, 108, Avenue Albert Raimond, 42055 Saint Etienne Cedex 2, France
    Prog Urol 22:572-6. 2012
    ..The aim of this article was to analyse the clinical features of multilocular cystic renal cell carcinoma with focus on CA9 expression...
  6. doi request reprint CA9 as a molecular marker for differential diagnosis of cystic renal tumors
    Guorong Li
    Department of Urology, North Hospital, CHU of Saint Etienne, Faculty of Medicine J Lisfranc, Jean Monnet University, Saint Etienne, France
    Urol Oncol 30:463-8. 2012
    ..The studies on CA9 have been limited to solid renal cell carcinomas (RCC). We have conducted a study of CA9 expression in renal cystic tumors. The purpose of the present study was to extend the utility of CA9 for cystic renal tumors...
  7. ncbi request reprint MN/CA9: a potential gene marker for detection of malignant cells in effusions
    G Li
    Laboratory of Clinical Immunology, North Hospital, CHU of Saint Etienne, France
    Biomarkers 12:214-20. 2007
    ..8% and 91.7%. Our preliminary results suggest that MN/CA9 could be a potential marker for the detection of malignant cells in effusions. A large-scale study is needed to confirm these results...
  8. doi request reprint [Results of fine-needle aspiration cytology (FNAC) in the diagnosis of indeterminate solid renal tumours]
    G Li
    Service d Urologie Andrologie, CHU de Saint Etienne, Université Jean Monnet, Saint Etienne, France
    Prog Urol 20:30-4. 2010
    ..To evaluate the accuracy of fine-needle aspiration cytology for the diagnosis of imaging indeterminate solid renal tumours...
  9. doi request reprint CA9 level in renal cyst fluid: a possible molecular diagnosis of malignant tumours
    Guorong Li
    Department of Urology, North Hospital, CHU of Saint Etienne, Faculty of Medicine, Jean Monnet University, Saint Etienne, France
    Histopathology 54:880-4. 2009
    ..The aim was to examine if the Carbonic anhydrase 9 (CA9) level in cyst fluid can provide a molecular diagnosis of malignant cyst...
  10. ncbi request reprint S100A1: a powerful marker to differentiate chromophobe renal cell carcinoma from renal oncocytoma
    G Li
    Department of Urology, North Hospital, CHU of Saint Etienne, France
    Histopathology 50:642-7. 2007
    ..The morphological differentiation between chromophobe carcinoma and oncocytoma may be difficult. The aim was to evaluate S100A1 as a new marker for the differentiation of the two subtypes...
  11. ncbi request reprint CA9 gene expression in conventional renal cell carcinoma: a potential marker for prediction of early metastasis after nephrectomy
    Guorong Li
    Department of Urology, North Hospital, CHU of Saint Etienne, 42055, Saint Etienne Cedex 2, France
    Clin Exp Metastasis 24:149-55. 2007
    ..CA9 may be a potential marker for the prediction of early metastasis after nephrectomy and to guide post-operative follow-up and treatment...
  12. ncbi request reprint The use of MN/CA9 gene expression in identifying malignant solid renal tumors
    Guorong Li
    Department of Urology, North Hospital, CHU of Saint Etienne, France
    Eur Urol 49:401-5. 2006
    ..MN/CA9 is one of the most powerful gene markers available for RCC. The objective of this pilot study is to utilize MN/CA9 gene expression in FNA biopsy to determine the malignancy of imaging-indeterminate solid renal tumors...
  13. ncbi request reprint Cadherin-6 gene expression in conventional renal cell carcinoma: a useful marker to detect circulating tumor cells
    Guorong Li
    Department of Urology, North Hospital, CHU of Saint Etienne, France
    Anticancer Res 25:377-81. 2005
    ..In this study, we evaluated cadherin-6 mRNA as a new molecular marker for the detection of circulating renal cancer cells...
  14. ncbi request reprint S100A1 and KIT gene expressions in common subtypes of renal tumours
    G Li
    Department of Urology, North Hospital, CHU of Saint Etienne, 42055 Saint Etienne Cedex 2, France
    Eur J Surg Oncol 31:299-303. 2005
    ..The aim of this study is to evaluate the S100A1 and KIT as gene markers for the differentiation of common subtypes of renal tumours...
  15. pmc Different DNA ploidy patterns for the differentiation of common subtypes of renal tumors
    Guorong Li
    Department of Urology, North Hospital, CHU of Saint Etienne, 42055 Saint Etienne Cedex 2, France
    Cell Oncol 27:51-6. 2005
    ..The aim of this study is to evaluate the DNA ploidy in the common subtypes of renal tumors to increase our understanding of renal tumor biology and to broaden clinical application of DNA ploidy...
  16. ncbi request reprint Characteristics of image-detected solid renal masses: implication for optimal treatment
    Guorong Li
    Department of Urology, North Hospital, Central University Hospital of Saint Etienne, France
    Int J Urol 11:63-7. 2004
    ..Solid renal masses are found increasingly. Further analysis of the characteristics of solid renal masses is useful for optimal treatment...
  17. ncbi request reprint Rapid and sensitive detection of messenger RNA expression for molecular differential diagnosis of renal cell carcinoma
    Guorong Li
    Department of Urology, North Hospital, CHU of Saint Etienne, Saint Etienne, France
    Clin Cancer Res 9:6441-6. 2003
    ..The aim of this study was to develop a practical technique to detect mRNA expression and to validate a panel of mRNA markers for molecular differential diagnosis of renal cell carcinoma (RCC)...
  18. doi request reprint Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer
    Guorong Li
    Department of Urology, North Hospital, CHU of Saint Etienne, Saint Etienne, France
    J Urol 180:510-3; discussion 513-4. 2008
    ..We explored the clinical usefulness of serum carbonic anhydrase 9 as a potential biomarker for conventional renal cell cancer...
  19. ncbi request reprint Evaluation of a panel of molecular markers for the diagnosis of malignant serous effusions
    Karine Passebosc-Faure
    Department of Immunology, University Hospital Center, Saint Etienne, France
    Clin Cancer Res 11:6862-7. 2005
    ..Our main goal was to evaluate a panel of molecular markers for the detection of cancer cells in serous effusions and to determine their value as an adjunctive reverse transcription-PCR (RT-PCR) test to cytologic examination...
  20. ncbi request reprint The in vivo DNA aneuploidization during expansion of conventional renal cell carcinoma
    Guorong Li
    Department of Urology, North Hospital, CHU of Saint Etienne, France
    In Vivo 16:341-4. 2002
    ..The molecular mechanism and the clinical significance of aneuploidy phenotypes need to be further investigated...
  21. doi request reprint CA9 as a biomarker in preoperative biopsy of small solid renal masses for diagnosis of clear cell renal cell carcinoma
    Guorong Li
    a Department of Urology, CHU de Saint Etienne, Saint Etienne, France
    Biomarkers 22:123-126. 2017
    ..The purpose of our study was to test the utility of CA9 expression in preoperative biopsy samples to identify the ccRCC...
  22. ncbi request reprint Elevated serum-circulating RNA in patients with conventional renal cell cancer
    Gang Feng
    Clinical Immunology Laboratory, North Hospital, CHU of Saint Etienne, France
    Anticancer Res 28:321-6. 2008
    ..The purpose of our study was to evaluate whether the amounts of circulating RNA could discriminate between conventional renal cancer patients and healthy individuals as a tumor marker...
  23. ncbi request reprint [Molecular and cytometric analysis of renal cell carcinoma cells. Concepts, techniques and prospects]
    Guorong Li
    Service d Urologie Andrologie, Hopital Nord, Saint Etienne, France
    Prog Urol 13:1-13. 2003
    ..Proteomic and genomic methods (biochips) should considerably accelerate research in this field leading to the development of routine clinical applications...
  24. ncbi request reprint Combination of core biopsy and fine-needle aspiration increases diagnostic rate for small solid renal tumors
    Guorong Li
    Department of Urology, North Hospital, CHU of Saint Etienne, 42055 Saint Etienne Cedex 2, France
    Anticancer Res 32:3463-6. 2012
    ..Our aim was to evaluate the performance of combination of fine-needle aspiration (FNA) and core biopsy (CB) as a method for the diagnosis of small solid renal tumors...
  25. doi request reprint Differential expression of prognostic markers in histological subtypes of papillary renal cell carcinoma
    Anne Gentil Perret
    Department of Pathology, North Hospital, CHU Saint Etienne, Saint Etienne, France
    BJU Int 102:183-7. 2008
    ..e. type 1 and type 2, the latter appearing to be associated with a poorer prognosis) and to determine whether any of these markers might be of prognostic value...
  26. ncbi request reprint The expression of G250/mn/CA9 antigen by flow cytometry: its possible implication for detection of micrometastatic renal cancer cells
    G Li
    Department of Urology, North Hospital, CHU of Saint-Etienne, France
    Clin Cancer Res 7:89-92. 2001
    ..FCM may serve as a fast tool of immunocytochemical detection of renal cancer cells. Flow cytometric detection of renal cancer cells by using mAb G250 should be further explored...
  27. doi request reprint Cell-free RNA content in urine as a possible molecular diagnostic tool for clear cell renal cell carcinoma
    An Zhao
    Department of Urology, North Hospital, CHU of Saint Etienne, University of Jean Monnet, Saint Etienne, France Zhejiang Cancer Research Institute, Zhejiang Province Cancer Hospital, Hangzhou, China
    Int J Cancer 136:2610-5. 2015
    ..The tumor-related gene VEGF mRNA fragment was detectable in the urine of cancer patients. Our finding may provide a new molecular assay for the diagnosis of renal cell carcinoma. ..
  28. doi request reprint Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma
    An Zhao
    Clinical Immunology Laboratory, North Hospital, CHU of Saint Etienne, University of Jean Monnet, Saint Etienne, France
    Exp Mol Pathol 94:115-20. 2013
    ..Our objective was to evaluate the levels of miR-210 in tumor and serum samples of conventional renal cell cancer (cRCC) patients to explore whether circulating miR-210 in serum can be used as a biomarker for the detection of cRCC...
  29. doi request reprint Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment
    Jacques Tostain
    Department of Urology Andrology, University Jean Monnet, Teaching Hospital, Saint Etienne, France
    Eur J Cancer 46:3141-8. 2010
    ..Targeting CA9 by inhibitors, radioimmunotherapy, monoclonal antibodies or vaccination is promising and offers new avenues for clinical research...
  30. ncbi request reprint [One-stage laparoscopic bilateral upper pole nephrectomy for ectopic insertion of complete ureteral duplication]
    Arnaud Pages
    Service d Urologie Andrologie, Hopital Nord, 42055 Saint Etienne
    Prog Urol 13:342-5. 2003
    ..Surgical treatment must comprise upper pole nephrectomy with partial ureterectomy. The authors report a case of one-stage retroperitoneal laparoscopic bilateral treatment which could become the treatment of choice of this disease...
  31. ncbi request reprint Flow cytometric analysis of antigen expression in malignant and normal renal cells
    G Li
    Department of Urology, North Hospital, CHU of Saint Etienne, France
    Anticancer Res 20:2773-8. 2000
    ..The aim of this study was to make a quantitative study of antigen expression in malignant and normal renal cells in order to find the efficient monoclonal antibodies (mAbs) for labelling renal cancer cells...
  32. ncbi request reprint Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma
    Vincenzo Ficarra
    Department of Urology, University of Verona, Verona, Italy
    Cancer 104:968-74. 2005
    ..The current study validated the 2002 edition of the TNM staging system in a multicenter, multinational European series of localized renal cell carcinoma (RCC)...
  33. ncbi request reprint Proposal for revision of the TNM classification system for renal cell carcinoma
    Vincenzo Ficarra
    Department of Urology, University of Verona, Verona, Italy
    Cancer 104:2116-23. 2005
    ..The current study defined an optimal tumor size breakpoint to stratify localized renal cell carcinoma (RCC) into groups with significantly different cancer-related outcomes and proposed a revision of the TNM classification system...